|
1
|
Murphey MD, Robbin MR, McRae GA, Flemming
DJ, Temple HT and Kransdorf MJ: The many faces of osteosarcoma.
Radiographics. 17:1205–1231. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Link MP, Goorin AM, Miser AW, et al: The
effect of adjuvant chemotherapy on relapse-free survival in
patients with osteosarcoma of the extremity. N Engl J Med.
314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen X, Yang TT, Wang W, et al:
Establishment and characterization of human osteosarcoma cell lines
with different pulmonary metastatic potentials. Cytotechnology.
61:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedenstein AJ, Chailakhyan RK, Latsinik
NV, Panasyuk AF and Keiliss-Borok IV: Stromal cells responsible for
transferring the microenvironment of the hemopoietic tissues.
Cloning in vitro and retransplantation in vivo. Transplantation.
17:331–340. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Austin TW, Solar GP, Ziegler FC, Liem L
and Matthews W: A role for the Wnt gene family in hematopoiesis:
expansion of multilineage progenitor cells. Blood. 89:3624–3635.
1997.PubMed/NCBI
|
|
6
|
Dexter TM, Spooncer E, Schofield R, Lord
BI and Simmons P: Haemopoietic stem cells and the problem of
self-renewal. Blood Cells. 10:315–339. 1984.PubMed/NCBI
|
|
7
|
Reya T, Duncan AW, Ailles L, et al: A role
for Wnt signalling in self-renewal of haematopoietic stem cells.
Nature. 423:409–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karnoub AE, Dash AB, Vo AP, et al:
Mesenchymal stem cells within tumour stroma promote breast cancer
metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oda Y, Yamamoto H, Tamiya S, et al: CXCR4
and VEGF expression in the primary site and the metastatic site of
human osteosarcoma: analysis within a group of patients, all of
whom developed lung metastasis. Mod Pathol. 19:738–745. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Dai K and Tang T: Effects of dextran
on proliferation and osteogenic differentiation of human bone
marrow-derived mesenchymal stromal cells. Cytotherapy. 10:587–596.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Z, Wu T, Lou H, et al: Inhibition of
breast cancer metastasis by selective synthetic polypeptide against
CXCR4. Cancer Res. 64:4302–4308. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kempf-Bielack B, Bielack SS, Jurgens H, et
al: Osteosarcoma relapse after combined modality therapy: an
analysis of unselected patients in the Cooperative Osteosarcoma
Study Group (COSS). J Clin Oncol. 23:559–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim J, Takeuchi H, Lam ST, et al:
Chemokine receptor CXCR4 expression in colorectal cancer patients
increases the risk for recurrence and for poor survival. J Clin
Oncol. 23:2744–2753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Retz MM, Sidhu SS, Blaveri E, et al: CXCR4
expression reflects tumor progression and regulates motility of
bladder cancer cells. Int J Cancer. 114:182–189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Russell HV, Hicks J, Okcu MF and Nuchtern
JG: CXCR4 expression in neuroblastoma primary tumors is associated
with clinical presentation of bone and bone marrow metastases. J
Pediatr Surg. 39:1506–1511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wada T, Isu K, Takeda N, Usui M, Ishii S
and Yamawaki S: A preliminary report of neoadjuvant chemotherapy
NSH-7 study in osteosarcoma: preoperative salvage chemotherapy
based on clinical tumor response and the use of granulocyte
colony-stimulating factor. Oncology. 53:221–227. 1996. View Article : Google Scholar
|
|
19
|
Beckermann BM, Kallifatidis G, Groth A, et
al: VEGF expression by mesenchymal stem cells contributes to
angiogenesis in pancreatic carcinoma. Br J Cancer. 99:622–631.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Djouad F, Plence P, Bony C, et al:
Immunosuppressive effect of mesenchymal stem cells favors tumor
growth in allogeneic animals. Blood. 102:3837–3844. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gunn WG, Conley A, Deininger L, Olson SD,
Prockop DJ and Gregory CA: A crosstalk between myeloma cells and
marrow stromal cells stimulates production of DKK1 and
interleukin-6: a potential role in the development of lytic bone
disease and tumor progression in multiple myeloma. Stem Cells.
24:986–991. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Otsu K, Das S, Houser SD, Quadri SK,
Bhattacharya S and Bhattacharya J: Concentration-dependent
inhibition of angiogenesis by mesenchymal stem cells. Blood.
113:4197–4205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Potier E, Ferreira E, Andriamanalijaona R,
et al: Hypoxia affects mesenchymal stromal cell osteogenic
differentiation and angiogenic factor expression. Bone.
40:1078–1087. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romieu-Mourez R, Francois M, Boivin MN,
Bouchentouf M, Spaner DE and Galipeau J: Cytokine modulation of TLR
expression and activation in mesenchymal stromal cells leads to a
proinflammatory phenotype. J Immunol. 182:7963–7973. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aboody KS, Brown A, Rainov NG, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Palma M, Venneri MA, Roca C and Naldini
L: Targeting exogenous genes to tumor angiogenesis by
transplantation of genetically modified hematopoietic stem cells.
Nat Med. 9:789–795. 2003.PubMed/NCBI
|
|
27
|
Xu WT, Bian ZY, Fan QM, Li G and Tang TT:
Human mesenchymal stem cells (hMSCs) target osteosarcoma and
promote its growth and pulmonary metastasis. Cancer Lett.
281:32–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bachelder RE, Wendt MA and Mercurio AM:
Vascular endothelial growth factor promotes breast carcinoma
invasion in an autocrine manner by regulating the chemokine
receptor CXCR4. Cancer Res. 62:7203–7206. 2002.
|
|
29
|
Plate K: From angiogenesis to
lymphangiogenesis. Nat Med. 7:151–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Nigris F, Balestrieri ML,
Williams-Ignarro S, et al: Therapeutic effects of autologous bone
marrow cells and metabolic intervention in the ischemic hindlimb of
spontaneously hypertensive rats involve reduced cell senescence and
CXCR4/Akt/eNOS pathways. J Cardiovasc Pharmacol. 50:424–433.
2007.PubMed/NCBI
|
|
31
|
de Nigris F, Crudele V, Giovane A, et al:
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during
malignancy. Proc Natl Acad Sci USA. 107:14484–14489.
2010.PubMed/NCBI
|
|
32
|
Lin F, Zheng SE, Shen Z, et al:
Relationships between levels of CXCR4 and VEGF and blood-borne
metastasis and survival in patients with osteosarcoma. Med Oncol.
28:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Busillo JM and Benovic JL: Regulation of
CXCR4 signaling. Biochim Biophys Acta. 1768:952–963. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Laverdiere C, Hoang BH, Yang R, et al:
Messenger RNA expression levels of CXCR4 correlate with metastatic
behavior and outcome in patients with osteosarcoma. Clin Cancer
Res. 11:2561–2567. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee YH, Tokunaga T, Oshika Y, et al:
Cell-retained isoforms of vascular endothelial growth factor (VEGF)
are correlated with poor prognosis in osteosarcoma. Eur J Cancer.
35:1089–1093. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Murakami T, Maki W, Cardones AR, et al:
Expression of CXC chemokine receptor-4 enhances the pulmonary
metastatic potential of murine B16 melanoma cells. Cancer Res.
62:7328–7334. 2002.PubMed/NCBI
|
|
38
|
Perissinotto E, Cavalloni G, Leone F, et
al: Involvement of chemokine receptor 4/stromal cell-derived factor
1 system during osteosarcoma tumor progression. Clin Cancer Res.
11:490–497. 2005.PubMed/NCBI
|
